Previous 10 | Next 10 |
2023-12-27 07:09:00 ET One of Apple 's (NASDAQ: AAPL) best-selling products is no longer being sold in the U.S. Starting Thursday, Dec. 21, online at 3 p.m. and in stores after Christmas Eve, the Apple Watch Series 9 and Watch Ultra 2 will no longer be sold as a result of an ongoing...
2023-12-26 07:25:56 ET More on Apple Apple: Losing The Magic Apple: Make No Mistake, Is The Smartwatch Sales Ban A Real Threat? Apple Set For A Market Surge In 2024 (Technical Analysis) Apple in $50M deal talks with publishers to train generative AI: report ...
2023-12-23 08:18:00 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha , iTunes , Spotify . For further details see: Wall Street Breakfast: What Moved Markets
2023-12-22 06:32:33 ET Summary Apple may face a ban on the sale of its Series 9 and Ultra 2 smartwatches in the US due to a patent dispute with medical technology company Masimo. The ban, if upheld, could potentially jeopardize around $5 billion in quarterly revenue for Apple. ...
2023-12-20 07:45:00 ET Summary The US Trade Representative will decide the patent dispute case between Apple and Masimo over sales of the Apple Watch. Atlanta Fed President Raphael Bostic does not see an urgency to cut interest rates next year. Toyota's unit Daihatsu is tempor...
2023-12-19 16:31:29 ET More on Apple Apple Watch Sales Ban Impact Analysis Apple: Potential Healthcare Giant In The Making Is Apple's Valuation Undermining Your Retirement? (Rating Downgrade) Apple mulls software workaround for watches hit by sales curbs - re...
2023-12-19 07:48:41 ET More on Apple and Masimo Apple: Potential Healthcare Giant In The Making Is Apple's Valuation Undermining Your Retirement? (Rating Downgrade) Apple's Growth Engine App Store On The Hook For Billions Of Dollars At Risk Masimo: Lots Of Mo...
2023-12-18 13:40:51 ET More on Masimo Masimo: Lots Of Moving Parts Apple halting Watch sales in compliance with ITC ruling; Biden may still veto Masimo W1 watch gets FDA clearance for OTC, prescription use For further details see: Masimo up 5% on FDA appr...
Stork Provides Continuous Monitoring of Oxygen Saturation, Pulse Rate, and Skin Temperature, with Alarms, for Sick and Healthy Babies at Home Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork...
2023-12-18 09:51:23 ET More on Apple and Masimo Apple: Potential Healthcare Giant In The Making Is Apple's Valuation Undermining Your Retirement? (Rating Downgrade) Apple's Growth Engine App Store On The Hook For Billions Of Dollars At Risk Apple reportedly f...
News, Short Squeeze, Breakout and More Instantly...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...
To ensure that Politan lies repeated over and over are not taken as fact, Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) sets forth below facts in response to what we believe are some of Politan’s and Quentin Koffey’s most egregious and con...